In a functional dyspepsia (FD) mouse model, both VIP receptor antagonists and ketotifen significantly reversed the proton pump inhibitor-mediated enhanced intestinal permeability and decreased transepithelial electrical resistance in the duodenum and jejunum, implicating VIP and MCs in the underlying mechanisms of FD [96]. Here, VIP is linked to Fabry disease.